TTY Biopharm Company Limited Logo

TTY Biopharm Company Limited (4105)

TWSE

Currency in TWD
77.80
-0.10 (-0.13%)

Closed

Aug 25, 2026

Day's Range

77.80
78.30

52 wk Range

71.60
87.00

Overview - 4105 - TTY Biopharm Company Limited

Key Statistics

Valuation

Enterprise Value

19.50B

P/E (Trailing)

‪11.19‬

P/E (Forward)

‪12.87‬

PEG Ratio

‪12.87‬

Price / Sales (TTM)

‪2.91‬

Price / Book

‪2.79‬

EV / EBITDA

‪9.46‬

Profitability

Gross Margin

‪59.99%‬

Profit Margin

‪26.04%‬

Operating Margin

‪29.48%‬

Return on Assets

‪10.34%‬

Return on Equity

‪25.11%‬

Ownership

Shares Outstanding

248.64M

Float

192.42M

Held by Insiders

‪23.10%‬

Held by Institutions

‪13.18%‬

Price stats

Beta

‪0.11‬

50-Day Avg

‪76.43‬

200-Day Avg

‪78.74‬

Dividends

Payout Ratio

‪64.66%‬

Frequency

Annual

Analyst Consensus

Buy

1 analysts

Market Cap - 4105 - TTY Biopharm Company Limited

Peers - 4105 - TTY Biopharm Company Limited

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.

Profile Summary - 4105 - TTY Biopharm Company Limited

About

TTY Biopharm Company Limited is a publicly traded pharmaceutical company specializing in the research, development, manufacture, and sale of pharmaceutical preparations. Established in 1960 and headquartered in Taipei, Taiwan, the company serves Taiwan’s pharmaceuticals and biotechnology sector, focusing primarily on…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.